한글목차

세계 휴대용 진단 기기 시장 규모는 조사 기간 동안 복합 연간 성장률(CAGR) 9.04%를 나타낼 전망입니다. 기술의 진보와 지속적인 감염의 빈도의 확대가 시장의 발전을 촉진하고 있습니다.

지역 분석

북미 시장은 휴대용 기기에 대한 관심 증가, 높은 치료율, 질병의 조기 발견을 향한 정부의 꾸준한 추진으로 최대 시장 점유율을 차지하고 추가 발전이 예측되고 있습니다.

유럽 시장은 미래에 2위 시장 규모를 기록할 것으로 예상됩니다. 이 지역의 성장은 최첨단 임상 장비의 보급, 높은 치료율, 조기 감염 발견을 향한 정부의 꾸준한 추진에 의해 촉진되고 추가 발전이 예측되고 있습니다.

아시아태평양 시장은 2023년부터 2030년까지 중대한 발전을 보여줄 전망입니다. 이는 노년 인구 증가, 당뇨병의 확대, 심장병의 발생률의 상승 등의 변수에 의한 것으로, 가처분 소득의 확대와 우수한 웨어러블의 수용이 시장의 발전을 뒷받침할 것으로 예측됩니다.

이 보고서는 세계 휴대용 진단 기기 시장에 대한 조사 분석, 시장 역학, 지역 및 부문 분석, 기업 프로파일 등을 제공합니다.

목차

제1장 주요 요약

제2장 시장의 소개

제3장 조사 방법

제4장 시장 역학

• 개요
• 성장 촉진요인
  • 기술의 진보
  • 만성질환의 발생률 증가
• 억제요인
  • 휴대용 진단 기기를 조작하기 위한 지식의 부족이 시장의 방해가 되고 있습니다
• 기회
  • 공공 및 민간 조직을 통한 자금 조달과 투자 증가

제5장 시장 요인 분석

• 밸류체인 분석
  • 연구개발 및 설계
  • 제조
  • 유통 및 판매
  • 판매 후 모니터링
• Porter's Five Forces 분석 모델
• 세계 휴대용 진단 기기 시장에 대한 COVID-19의 영향
  • 공급망에 미치는 영향
  • 생산에 미치는 영향
  • 지역에 미치는 영향
  • 공급 갭 분석에 미치는 영향
  • 가격에 미치는 영향

제6장 세계 휴대용 진단 기기 시장 : 유형별

• 개요
• 화상 진단
  • CT 스캔
  • X선
  • 초음파
  • 내시경
• 모니터링 기기
  • 심장 모니터링
  • 신경 모니터링
  • 호흡 모니터링
  • 안과 모니터링
  • 혈역학적 모니터링 시스템
  • 바이탈 사인 모니터
  • 스마트 웨어러블 의료기기
  • 기타

제7장 세계 휴대용 진단 기기 시장 : 용도별

• 개요
• 산부인과
• 심장
• 위장
• 비뇨기과
• 신경
• 호흡기
• 정형외과
• 안과
• 기타

제8장 세계 휴대용 진단 기기 시장 : 최종 사용자별

• 개요
• 병원 및 진료소
• 진단센터
• 재택 케어 환경
• 기타

제9장 세계 휴대용 진단기기 시장 : 지역별

• 개요
• 세계
• 북미
  • 미국
  • 캐나다
• 유럽
  • 독일
  • 영국
  • 프랑스
  • 이탈리아
  • 스페인
  • 기타 유럽
• 아시아태평양
  • 중국
  • 인도
  • 일본
  • 호주
  • 한국
  • 기타 아시아태평양
• 기타 지역
  • 중동
  • 아프리카
  • 라틴아메리카

제10장 경쟁 구도

• 개요
• 경쟁 벤치마킹
• 세계 휴대용 진단 기기 시장의 주요 성장 전략
• 세계 휴대용 진단 기기 시장에서 개발 수의 주요 기업
• 주요 개발 분석
• 주요 발전과 성장 전략
  • 제품 출시 및 제품 승인
  • 파트너십, 협정 및 제휴
• 주요 기업의 매출 분석
  • 매출 및 영업이익
• 주요 기업의 연구 개발 분석

제11장 기업 프로파일

• F. HOFFMANN-LA ROCHE LTD
• GE HEALTHCARE
• MEDTRONIC
• OMRON HEALTHCARE, INC.
• KONINKLIJKE PHILIPS NV
• ABBOTT
• SAMSUNGHEALTHCARE.COM
• STRYKER
• WELLUE
• EMAY

영문목차

Market Overview

Portable Diagnostic Devices Market is projected to register a healthy CAGR of 9.04% during the review period. The developing mechanical progressions and expanding frequencies of persistent infections are driving market development.

The developing mechanical progressions in portable diagnostics offer advantages like reasonableness, patient wellbeing, and fast and quality conclusion. The market players are bringing new innovations into portable devices, like 3D ultrasound, high level elements and apparatuses at fingertips, and remote ultrasound, which are driving the market's development. For example, February 2023: Mindray (China) sent off the remote handheld ultrasound framework TE Air, which is explicitly intended to satisfy the need of worldwide medical services experts. It is easy to use in various clinical settings and gives clear place of-care ultrasound (POCUS) imaging.

Moreover, the ascent in ongoing sicknesses is a basic element pushing market development. Malignant growth, coronary illness, diabetes, weight, and constant respiratory infections are among the most well-known and quickly expanding ongoing sicknesses. In September 2022, the Worldwide Drive for Ongoing Obstructive Cellular breakdown in the lungs reported that around 200 million individuals overall have persistent obstructive pneumonic sickness (COPD) and 262 million individuals are impacted by asthma every year.

Market Segmentation

Portable diagnostic devices market segmentation is based on type and is divided into diagnostic imaging devices and monitoring devices. Portable diagnostic devices market segmentation is based on applications divided into gynecology, cardiology, gastrointestinal, urology, neurology, respiratory, orthopedics, ophthalmology and others. The segmentation of the portable diagnostic devices market is based on the division of end users into hospitals and hospitals. Clinics, diagnostic centers, home care facilities and others. The hospitals and clinics segment dominated the market in 2022 and projected to be the fastest-growing during the forecast period, 2023-2030.

Regional Analysis

The North America Portable Diagnostic Devices market represented the biggest market share owing to the rising interest for portable devices, high treatment rates, and steady government drives for early finding of illnesses is additionally expected to cultivate North America's market development.

Europe Portable Diagnostic Devices market is anticipated to register the second-biggest market in future. The regional growth is drien by the Rising reception of cutting edge clinical devices, high treatment rates and steady government drives for early infection discovery is additionally expected to help the development of the market.

The Asia-Pacific Portable Diagnostic Devices market is supposed to develop at a critical offer from 2023 to 2030. This is because of variables like the ascent in the geriatric populace, the developing predominance of diabetes, raising occurrences of heart sicknesses, and an expansion in extra cash alongside the reception of brilliant wearables is additionally expected to support the market development.

Major Players

Key Companies in the Portable Diagnostic Devices Market are Hoffmann-La Roche Ltd, GE Healthcare, Medtronic, Omron Healthcare Inc., Koninklijke Philips N.V., Abbott, COM, Stryker, Wellue, and EMAY.

TABLE OF CONTENTS

TABLE OF CONTENTS

1 EXECUTIVE SUMMARY

• 1.1 OVERVIEW

2 MARKET INTRODUCTION

• 2.1 DEFINITION
• 2.2 SCOPE OF THE STUDY
• 2.3 RESEARCH OBJECTIVE
• 2.4 MARKET STRUCTURE
• 2.5 ASSUMPTIONS & LIMITATIONS

3 RESEARCH METHODOLOGY

• 3.1 DATA MINING
• 3.2 SECONDARY RESEARCH
• 3.3 PRIMARY RESEARCH
• 3.4 BREAKDOWN OF PRIMARY RESPONDENTS
• 3.5 FORECASTING TECHNIQUES
• 3.6 RESEARCH METHODOLOGY FOR MARKET SIZE ESTIMATION
  • 3.6.1 BOTTOM-UP APPROACH
  • 3.6.2 TOP-DOWN APPROACH
• 3.7 DATA TRIANGULATION
• 3.8 VALIDATION

4 MARKET DYNAMICS

• 4.1 OVERVIEW
• 4.2 DRIVERS
  • 4.2.1 GROWING TECHNOLOGICAL ADVANCEMENTS
  • 4.2.2 INCREASING INCIDENCES OF CHRONIC DISEASES
• 4.3 RESTRAINTS
  • 4.3.1 LACK OF KNOWLEDGE TO RUN PORTABLE DIAGNOSTIC DEVICES IS A HINDRANCE TO THE MARKET
• 4.4 OPPORTUNITIES
  • 4.4.1 INCREASING FUNDING AND INVESTMENT THROUGH A PUBLIC AND PRIVATE ORGANIZATIONS

5 MARKET FACTOR ANALYSIS

• 5.1 VALUE CHAIN ANALYSIS
  • 5.1.1 R&D & DESIGNING
  • 5.1.2 MANUFACTURING
  • 5.1.3 DISTRIBUTION & SALES
  • 5.1.4 POST-SALES MONITORING
• 5.2 PORTER'S FIVE FORCES MODEL
  • 5.2.1 THREAT OF NEW ENTRANTS
  • 5.2.2 BARGAINING POWER OF SUPPLIERS
  • 5.2.3 THREAT OF SUBSTITUTES
  • 5.2.4 BARGAINING POWER OF BUYERS
  • 5.2.5 INTENSITY OF RIVALRY
• 5.3 IMPACT OF COVID-19 ON THE GLOBAL PORTABLE DIAGNOSTIC DEVICES MARKET
  • 5.3.1 IMPACT ON SUPPLY CHAIN
  • 5.3.2 IMPACT ON PRODUCTION
  • 5.3.3 IMPACT ON REGIONS
  • 5.3.4 IMPACT ON SUPPLY GAP ANALYSIS
  • 5.3.5 IMPACT ON PRICING

6 GLOBAL PORTABLE DIAGNOSTIC DEVICES MARKET, BY TYPE

• 6.1 OVERVIEW
• 6.2 DIAGNOSTIC IMAGING
  • 6.2.1. CT Scan
  • 6.2.2. X-Ray
  • 6.2.3. Ultrasound
  • 6.2.4. Endoscopes
• 6.3. MONITORING DEVICES
  • 6.3.1. Cardiac Monitoring
    • 6.3.1.1. Holter Monitors
    • 6.3.1.2. Resting ECG System
    • 6.3.1.3. Stress ECG Monitors
    • 6.3.1.4. Event Monitoring Systems
    • 6.3.1.5. ECG Management Systems
  • 6.3.2. Neuromonitoring
    • 6.3.2.1. EEG Machines
    • 6.3.2.2. EMG Machines
    • 6.3.2.3. ICP Monitors
    • 6.3.2.4. MEG Machines
    • 6.3.2.5. Cerebral Oximeters
  • 6.3.3. Respiratory Monitoring
    • 6.3.3.1. Capnographs
    • 6.3.3.2. Spirometers
    • 6.3.3.3. Peak Flow Meters
  • 6.3.4. Ophthalmic Monitoring
    • 6.3.4.1. Fundus Cameras
    • 6.3.4.2. Tonometry Devices
    • 6.3.4.3. Others
  • 6.3.5. Hemodynamic Monitoring Systems
  • 6.3.6. Vital Sign Monitors
  • 6.3.7. Smart Wearable Medical Device
  • 6.3.8. Others

7 GLOBAL PORTABLE DIAGNOSTIC DEVICES MARKET, BY APPLICATION

• 7.1 OVERVIEW
• 7.2 GYNAECOLOGY
• 7.3 CARDIOLOGY
• 7.4 GASTROINTESTINAL
• 7.5 UROLOGY
• 7.6 NEUROLOGY
• 7.7 RESPIRATORY
• 7.8 ORTHOPEDICS
• 7.9 OPTHALMOLOGY
• 7.10 OTHERS

8 GLOBAL PORTABLE DIAGNOSTIC DEVICES MARKET, BY END USER

• 8.1 OVERVIEW
• 8.2 HOSPITALS & CLINICS
• 8.3 DIAGNOSTIC CENTERS
• 8.4 HOMECARE SETTINGS
• 8.5 OTHERS

9 GLOBAL PORTABLE DIAGNOSTIC DEVICES MARKET, BY REGION

• 9.1 OVERVIEW
• 9.2 GLOBAL
• 9.3 NORTH AMERICA
  • 9.3.1 US
  • 9.3.2 CANADA
• 9.4 EUROPE
  • 9.4.1 GERMANY
  • 9.4.2 UK
  • 9.4.3 FRANCE
  • 9.4.4 ITALY
  • 9.4.5 SPAIN
  • 9.4.6 REST OF EUROPE
• 9.5 ASIA-PACIFIC
  • 9.5.1 CHINA
  • 9.5.2 INDIA
  • 9.5.3 JAPAN
  • 9.5.4 AUSTRALIA
  • 9.5.5 SOUTH KOREA
  • 9.5.6 REST OF ASIA-PACIFIC
• 9.6 REST OF THE WORLD
  • 9.6.1 MIDDLE EAST
  • 9.6.2 AFRICA
  • 9.6.3 LATIN AMERICA

10 COMPETITIVE LANDSCAPE

• 10.1 OVERVIEW
• 10.2 COMPETITIVE BENCHMARKING
• 10.3 MAJOR GROWTH STRATEGY IN THE GLOBAL PORTABLE DIAGNOSTIC DEVICES MARKET
• 10.4 THE LEADING PLAYER IN TERMS OF THE NUMBER OF DEVELOPMENTS IN THE GLOBAL PORTABLE DIAGNOSTIC DEVICES MARKET
• 10.5 KEY DEVELOPMENT ANALYSIS
• 10.6 KEY DEVELOPMENTS & GROWTH STRATEGIES
  • 10.6.1 PRODUCT LAUNCH/PRODUCT APPROVAL
  • 10.6.2 PARTNERSHIP/ AGREEMENT/COLLABORATION
• 10.7 MAJOR PLAYERS SALES ANALYSIS
  • 10.7.1 SALES & OPERATING INCOME
• 10.8 MAJOR PLAYERS R&D ANALYSIS

11 COMPANY PROFILE

• 11.1 F. HOFFMANN-LA ROCHE LTD
  • 11.1.1 COMPANY OVERVIEW
  • 11.1.2 FINANCIAL OVERVIEW
  • 11.1.3 PRODUCTS OFFERED
  • 11.1.4 KEY DEVELOPMENTS
  • 11.1.5 KEY STRATEGIES
• 11.2 GE HEALTHCARE
  • 11.2.1 COMPANY OVERVIEW
  • 11.2.2 FINANCIAL OVERVIEW
  • 11.2.3 PRODUCTS OFFERED
  • 11.2.4 KEY DEVELOPMENTS
  • 11.2.5 SWOT ANALYSIS
  • 11.2.6 KEY STRATEGIES
• 11.3 MEDTRONIC
  • 11.3.1 COMPANY OVERVIEW
  • 11.3.2 FINANCIAL OVERVIEW
  • 11.3.3 PRODUCTS OFFERED
  • 11.3.4 KEY DEVELOPMENTS
  • 11.3.5 SWOT ANALYSIS
  • 11.3.6 KEY STRATEGIES
• 11.4 OMRON HEALTHCARE, INC.
  • 11.4.1 COMPANY OVERVIEW
  • 11.4.2 FINANCIAL OVERVIEW
  • 11.4.3 PRODUCTS OFFERED
  • 11.4.4 KEY DEVELOPMENTS
  • 11.4.5 KEY STRATEGIES
• 11.5 KONINKLIJKE PHILIPS N.V.
  • 11.5.1 COMPANY OVERVIEW
  • 11.5.2 FINANCIAL OVERVIEW
  • 11.5.3 PRODUCTS OFFERED
  • 11.5.4 KEY DEVELOPMENTS
  • 11.5.5 SWOT ANALYSIS
  • 11.5.6 KEY STRATEGIES
• 11.6 ABBOTT
  • 11.6.1 COMPANY OVERVIEW
  • 11.6.2 FINANCIAL OVERVIEW
  • 11.6.3 PRODUCTS OFFERED
  • 11.6.4 KEY DEVELOPMENTS
  • 11.6.5 SWOT ANALYSIS
  • 11.6.6 KEY STRATEGIES
• 11.7 SAMSUNGHEALTHCARE.COM
  • 11.7.1 COMPANY OVERVIEW
  • 11.7.2 FINANCIAL OVERVIEW
  • 11.7.3 PRODUCTS OFFERED
  • 11.7.4 KEY DEVELOPMENTS
  • 11.7.5 KEY STRATEGIES
• 11.8 STRYKER
  • 11.8.1 COMPANY OVERVIEW
  • 11.8.2 FINANCIAL OVERVIEW
  • 11.8.3 PRODUCTS OFFERED
  • 11.8.4 KEY DEVELOPMENTS
  • 11.8.5 KEY STRATEGIES
• 11.9 WELLUE
  • 11.9.1 COMPANY OVERVIEW
  • 11.9.2 FINANCIAL OVERVIEW
  • 11.9.3 PRODUCTS OFFERED
  • 11.9.4 KEY DEVELOPMENTS
  • 11.9.5 KEY STRATEGIES
• 11.10 EMAY
  • 11.10.1 COMPANY OVERVIEW
  • 11.10.2 FINANCIAL OVERVIEW
  • 11.10.3 PRODUCTS OFFERED
  • 11.10.4 KEY DEVELOPMENTS
  • 11.10.5 KEY STRATEGIES